PETVIVO HOLDING, INC. ANNOUNCES PARTNERSHIP ENGAGEMENTS WITH VEDCO, INC. AND CLIPPER DISTRIBUTING, LLC
PetVivo Holdings (OTCQB: PETV) has announced new distribution partnerships with Vedco Inc. and Clipper Distributing, , both major players in veterinary product distribution. These partnerships will expand the distribution network for PetVivo's flagship product, Spryng™ with OsteoCushion™ Technology, an intra-articular injectable veterinary medical device designed to manage joint pain in animals.
The partnerships connect PetVivo to major national veterinary product distributors including MWI, Covetrus, Patterson, Midwest Supply, and Penn Supply. Spryng is designed to promote joint pain management by augmenting and reinforcing cartilage to support normal joint function in cases where there is loss of cartilage or tissue-bone mechanical malfunction.
PetVivo Holdings (OTCQB: PETV) ha annunciato nuove partnership di distribuzione con Vedco Inc. e Clipper Distributing, entrambi importanti attori nella distribuzione di prodotti veterinari. Queste collaborazioni espanderanno la rete di distribuzione per il prodotto di punta di PetVivo, Spryng™ con Tecnologia OsteoCushion™, un dispositivo medico veterinario iniettabile intra-articolare progettato per gestire il dolore articolare negli animali.
Le partnership collegano PetVivo a importanti distributori nazionali di prodotti veterinari, tra cui MWI, Covetrus, Patterson, Midwest Supply e Penn Supply. Spryng è progettato per favorire la gestione del dolore articolare potenziando e rinforzando la cartilagine per supportare la normale funzione articolare in casi di perdita di cartilagine o malfunzionamento meccanico tessuto-osseo.
PetVivo Holdings (OTCQB: PETV) ha anunciado nuevas asociaciones de distribución con Vedco Inc. y Clipper Distributing, ambos actores importantes en la distribución de productos veterinarios. Estas asociaciones ampliarán la red de distribución para el producto insignia de PetVivo, Spryng™ con Tecnología OsteoCushion™, un dispositivo médico veterinario inyectable intraarticular diseñado para manejar el dolor articular en animales.
Las asociaciones conectan a PetVivo con importantes distribuidores nacionales de productos veterinarios, incluyendo MWI, Covetrus, Patterson, Midwest Supply y Penn Supply. Spryng está diseñado para promover la gestión del dolor articular al aumentar y reforzar el cartílago para apoyar la función articular normal en casos de pérdida de cartílago o mal funcionamiento mecánico del tejido óseo.
PetVivo Holdings (OTCQB: PETV)는 Vedco Inc.와 Clipper Distributing와의 새로운 유통 파트너십을 발표했습니다. 두 회사는 모두 수의학 제품 유통의 주요 선수입니다. 이러한 파트너십을 통해 PetVivo의 대표 제품인 Spryng™ with OsteoCushion™ Technology의 유통 네트워크가 확장될 것입니다. 이는 동물의 관절 통증을 관리하도록 설계된 관절 내 주사형 수의학 의료 장치입니다.
이 파트너십은 PetVivo를 MWI, Covetrus, Patterson, Midwest Supply 및 Penn Supply를 포함한 주요 국가 수의학 제품 유통업체와 연결합니다. Spryng은 연골이 손실되거나 조직-뼈의 기계적 고장이 있는 경우 정상적인 관절 기능을 지원하기 위해 연골을 보강하고 강화함으로써 관절 통증 관리를 촉진하도록 설계되었습니다.
PetVivo Holdings (OTCQB: PETV) a annoncé de nouveaux partenariats de distribution avec Vedco Inc. et Clipper Distributing, deux acteurs majeurs dans la distribution de produits vétérinaires. Ces partenariats élargiront le réseau de distribution du produit phare de PetVivo, Spryng™ avec la Technologie OsteoCushion™, un dispositif médical vétérinaire injectable intra-articulaire conçu pour gérer la douleur articulaire chez les animaux.
Ces partenariats connectent PetVivo à de grands distributeurs nationaux de produits vétérinaires, notamment MWI, Covetrus, Patterson, Midwest Supply et Penn Supply. Spryng est conçu pour promouvoir la gestion de la douleur articulaire en augmentant et en renforçant le cartilage pour soutenir la fonction articulaire normale en cas de perte de cartilage ou de dysfonctionnement mécanique des tissus et des os.
PetVivo Holdings (OTCQB: PETV) hat neue Vertriebspartnerschaften mit Vedco Inc. und Clipper Distributing angekündigt, beide bedeutende Akteure im Vertrieb von Veterinärprodukten. Diese Partnerschaften werden das Vertriebsnetz für PetVivos Hauptprodukt, Spryng™ mit OsteoCushion™ Technologie, erweitern, ein intraartikuläres injizierbares veterinärmedizinisches Gerät, das zur Behandlung von Gelenkschmerzen bei Tieren entwickelt wurde.
Die Partnerschaften verbinden PetVivo mit wichtigen nationalen Vertriebsunternehmen für Veterinärprodukte wie MWI, Covetrus, Patterson, Midwest Supply und Penn Supply. Spryng ist darauf ausgelegt, die Verwaltung von Gelenkschmerzen zu fördern, indem es den Knorpel verstärkt und unterstützt, um die normale Gelenkfunktion in Fällen von Knorpelverlust oder mechanischem Versagen von Gewebe und Knochen zu unterstützen.
- Strategic partnerships with two major veterinary product distributors expanding market reach
- Access to major national distribution networks including MWI, Covetrus, Patterson
- Enhanced product accessibility for veterinarians nationwide
- None.
MINNEAPOLIS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) ("PetVivo"), a pioneering biomedical technology company focused on adapting human biotech, medical device and other therapeutic technologies into osteoarthritis and lameness products for commercial sale in the US companion animal and equine markets, announces new distribution partnerships with Vedco Inc. (“Vedco”), and Clipper Distributing, LLC (“Clipper”), both leaders in logistical solutions and supply of products to veterinarians through the channel-of-distribution for veterinarians. Vedco and Clipper distribute to many of the largest national veterinary product distribution entities in the United States, including MWI, Covetrus, Patterson, Midwest Supply and Penn Supply, to just name a few.
“Spryng™ with OsteoCushion™ Technology is an innovative intra-articular injectable veterinary medical device that is designed to promote the management of joint pain caused by the loss of cartilage or tissue-bone mechanical malfunction; Spryng assists in augmenting and reinforcing cartilage to support the normalization of joint function. Our partnerships with Vedco and Clipper marks the beginning of what promises to be significant, and mutually beneficial relationships aimed at elevating the standard of veterinary care,” said Mike Eldred, Board Member and Commercial Executive at PetVivo.
"We are excited to be associated with PetVivo on the distribution of their unique Spryng with OsteoCushion Technology family of products,” said Craig Campbell, General Manager of Vedco. “This groundbreaking product aligns perfectly with Vedco's commitment to bringing innovative and high-value solutions to our distribution partners, while offering highly effective and safe solutions for veterinary hospitals and their clients.”
Corey Shigematsu, Chief Executive Officer at Clipper commented, “Expanding the distribution network for Spryng and its OsteoCushion Technology ensures that veterinarians across the country have access to one of the newest solutions on the market.”
For more information about PetVivo Holdings, Inc. and its innovative product, Spryng, please contact info1@petvivo.com or visit https://petvivo.com/ and https://sprynghealth.com/.
About PetVivo Holdings, Inc.
PetVivo Holdings Inc. (OTCQB: PETV & PETVW) is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for the treatment of animals and people. A portfolio of twenty patents protects the Company's biomaterials, products, production processes and methods of use. The Company’s lead product SPRYNG, a veterinarian-administered, intraarticular injection for the treatment of lameness and other joint-related afflictions, including osteoarthritis, in dogs and horses, is currently available for commercial sale to veterinarians.
CONTACT:
John Lai, CEO
PetVivo Holdings, Inc.
Email: info1@petvivo.com
(952) 405-6216
Forward-Looking commercial Statements:
The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2023 and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
FAQ
What are the new distribution partnerships announced by PetVivo (PETV) in January 2024?
Which major distributors will PetVivo (PETV) reach through the Vedco and Clipper partnerships?
What is Spryng with OsteoCushion Technology by PetVivo (PETV)?
How will the new distribution partnerships impact PetVivo's (PETV) market reach?
